Geofencing Components and Existing Models

This paper describes the various Geofencing Components and Existing Models in terms of their Information Security Control Attribute Profiles. The profiles will dictate the security attributes that should accompany each and every Geofencing Model used for Wi-Fi network security control in an organization, thus minimizing the likelihood of malfunctioning security controls. Although it is up to an organization to investigate the best way of implementing information security for itself, by looking at the related models that have been used in the past this paper will present models commonly used to implement information security controls in the organizations. Our findings will highlight the strengths and weaknesses of the various models and present what our experiment and prototype consider as a robust Geofencing Security Model for securing Wi-Fi Networks

Phenomenology and Poststructuralism

This work is part of a collection titled The Edinburgh Companion to Critical Theory, edited by Stuart Sim (Edinburgh: Edinburgh University Press, 2016) https://edinburghuniversitypress.com/ For personal use only.

Understanding the non-pharmacological correlates of self-reported efficacy of antidepressants

Objective: To explore the non-pharmacological correlates of the perceived effectiveness of antidepressants (ADs), thereby enhancing understanding of the mechanisms involved in recovery from depression while taking ADs. Method: An online survey was completed by 1781 New Zealand adults who had taken ADs in the previous 5 years. Results: All 18 psychosocial variables measured were associated with depression reduction, and 16 with improved quality of life (QoL). Logistic regression models revealed that the quality of the relationship with the prescriber was related to both depression reduction and improved QoL. In addition, depression reduction was related to younger age, higher income, being fully informed about ADs by the prescriber, fewer social causal beliefs for depression and not having lost a loved one in the 2 months prior to prescription. Furthermore, both outcome measures were positively related to belief in ‘chemical’ rather than ‘placebo’ effects. Conclusion: There are multiple non-pharmacological processes involved in recovery while taking ADs. Enhancing them, for example focusing on the prescriber–patient relationship and giving more information, may enhance recovery rates, with or without ADs.